BY NATALIE PRIEB  Pharmaceutical company Merck on Friday said it will seek an emergency authorization for its oral antiviral COVID-19 treatment after the medicine was shown to reduce the risk of hospitalization by 50 percent during clinical trials. An analysis of...

read more